ftInvstr
VIYASH · Healthcare ₹237.0 +0.99% Mkt Cap ₹10313 Cr overvalued
← Search another stock

VIYASH

Healthcare Drug Manufacturers - Specialty & Generic
★ Watchlist ⧉ Add to bucket
₹237.0
+0.99% today · 30d +1.28%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for VIYASH. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹946 Cr
+114.39% YoY
NET PROFIT
₹79 Cr
+351.28% YoY
OPM
19.56%
+6.97pp YoY
EPS
₹1.51
PE 62.26
Intrinsic value · DCF ₹79.25 · Margin of safety -66.6% (overvalued) · FCF yield 1.82%
◇ Sector Position
PEERPEROCE %
VIYASH62.2619.0
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
64
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation STRETCHED 20
Growth STRONG 85
Profitability HIGH 78
Technicals WEAK 47
Risk LOW 80
Key Stats
TTM PE
62.26
P/B
3.82
52W HIGH
₹298.0
OFF HIGH
-20.47%
DIV YIELD
0.0%
MKT CAP
₹10313 Cr
◉ Active Signals
MACDNeutral3.2707
RSI(14)Neutral56.32
Street Consensus
4 analysts
₹326.0
mean target
Low ₹310.0Now ₹237.0High ₹340.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold VIYASH and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.